peptide therapeutics

Protagonist Therapeutics, Newark, California, August 28, 2026 Protagonist Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...

INCHEON, South Korea, July 20, 2026 Samsung Biologics has announced a landmark all-cash public tender offer to acquire 100%...

MEQUON, Wis., July 7, 2026 Vector Science & Therapeutics Corp. has entered into a landmark exclusive licensing and cGMP...

BEIJING, China, July 6, 2026 InnoCare Pharma has announced a significant milestone in its oncology pipeline with the first...

HONG KONG, July 6, 2026 Ascletis Pharma Inc. has announced the submission of two Investigational New Drug (IND) applications...

MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...

COPENHAGEN, Denmark, May 27, 2026 Zealand Pharma announced that new clinical data from its obesity and metabolic disease pipeline...

TARRYTOWN, N.Y., May 21, 2026 Sapience Therapeutics has announced encouraging updated clinical data from its ongoing Phase 2 trial...

RAHWAY, N.J., May 7, 2026 Merck announced the publication of a landmark scientific paper in the journal Science detailing...

Toronto, Canada | May 1, 2026 Apotex has received Health Canada approval for Apo-Semaglutide Injection™, a generic equivalent of...